Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
Clinical trial NCT01369095 · COMPLETED
Trial details
- NCT number
- NCT01369095
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-07-01
- Primary completion
- 2013-05-01
- Enrollment
- 976
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.